Skip to main content

Anshul Shah, BS Pharm, MS

Authored Items
Economic Implications of Preventing Major Cardiovascular and Limb Events with Rivaroxaban plus Aspirin in Patients with Coronary or Peripheral Artery Disease in the United States
Luis Hernandez, MSc, MPH, Anshul Shah, BS Pharm, MS, Qi Zhao, MD, Dejan Milentijevic, PhD, MBA, Akshay Kharat, PhD
October/November 2020 Vol 13, No 5 in Original Research, Practice Management
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Atheer A. Kaddis, PharmD, Chakkarin Burudpakdee, PharmD, Anshul Shah, BS Pharm, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
December 2014 Vol 7, No 9 in Practice Management
Last modified: November 30, 2020